4.4 Article

Quantitive evaluation of macromolecular crystallization experiments using 1,8-ANS fluorescence

Journal

Publisher

WILEY-BLACKWELL
DOI: 10.1107/S0907444910020664

Keywords

-

Ask authors/readers for more resources

Modern X-ray structure analysis and advances in high-throughput robotics have allowed a significant increase in the number of conditions screened for a given sample volume. An efficient evaluation of the increased amount of crystallization trials in order to identify successful experiments is now urgently required. A novel approach is presented for the visualization of crystallization experiments using fluorescence from trace amounts of a nonspecific dye. The fluorescence images obtained strongly contrast protein crystals against other phenomena, such as precipitation and phase separation. Novel software has been developed to quantitatively evaluate the crystallization outcome based on a biophysical metric correlated with voxel protein concentration. In > 1500 trials, 85.6% of the successful crystallization experiments were correctly identified, yielding a 50% reduction in the number of 'missed hits' compared with current automated approaches. The use of the method in the crystallization of three previously uncharacterized proteins from the malarial parasite Plasmodium falciparum is further demonstrated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Oncology

Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the

Bart Koopman, Harry J. M. Groen, Ed Schuuring, T. Jeroen N. Hiltermann, Wim Timens, Wilfred F. A. den Dunnen, Anke van den Berg, Arja Ter Elst, Michel van Kruchten, Joost L. Kluiver, Birgitta Hiddinga, Lucie B. M. Hijmering-Kappelle, Matthew R. Groves, Juliana F. Vilacha, Leon C. van Kempen, Anthonie J. van der Wekken

Summary: This study provides clinical evidence for targeting on-target resistance mutations in ALK-fusion-positive NSCLC patients treated with ALK inhibitors. The clinical benefit varies for different mutation-inhibitor combinations. Such comprehensive overview can guide the treatment of similar patients in clinical practice.

CLINICAL LUNG CANCER (2022)

Review Biology

In memory of Margarita Malakyan, a bright person and inquisitive scientist

Mariam Petrosyan, Elina Arakelova, Lyudmila Nersesova, Violetta Ayvazyan, Gohar Tsakanova

Summary: Margarita Malakyan was an active and initiative radiobiologist whose collaboration with chemists, physicists, and biologists around the world led to the development of radioprotectors and radiosensitizers. Her work in synthesizing, characterizing, and studying the toxicity of metal complexes of Schiff bases suggested their effectiveness as radioprotective agents and radiosensitizers.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2022)

Article Chemistry, Medicinal

Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein

Afsaneh Sadremomtaz, Zayana M. Al-Dahmani, Angel J. Ruiz-Moreno, Alessandra Monti, Chao Wang, Taha Azad, John C. Bell, Nunzianna Doti, Marco A. Velasco-Velazquez, Debora de Jong, Jorgen de Jonge, Jolanda Smit, Alexander Domling, Harry van Goor, Matthew R. Groves

Summary: This study identified hotspot interactions on ACE2 using protein contact atlas data and molecular dynamics simulations. Discontinuous peptides were designed based on these interactions and showed high efficacy in inhibiting the SARS-CoV-2 infection. These peptides, with strong binding affinity to S-RBD, hold potential as efficient therapeutic treatment for COVID-19.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of 1,5-disubstituted a-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders

Fausta Ulgheri, Pietro Spanu, Francesco Deligia, Giovanni Loriga, Maria Pia Fuggetta, Iris de Haan, Ajay Chandgudge, Matthew Groves, Alexander Domling

Summary: Using a mixed modelling, computational screening, synthesis and in vitro testing approach, a novel class of non-covalent caspase-1 inhibitors was identified. These inhibitors effectively inhibit IL-1 beta release in activated macrophages, showing potential for the treatment of inflammation and inflammatory diseases.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Multidisciplinary Sciences

First crystal structures of 1-deoxy-d-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization

Robin M. Gierse, Rick Oerlemans, Eswar R. Reddem, Victor O. Gawriljuk, Alaa Alhayek, Dominik Baitinger, Harald Jakobi, Bernd Laber, Gudrun Lange, Anna K. H. Hirsch, Matthew R. Groves

Summary: The development of drug resistance highlights the importance of new antibiotics. Most bacteria synthesize isoprenoid precursors through the MEP pathway, making 1-deoxy-d-xylulose 5-phosphate synthase (DXPS) an attractive target. In this study, the DXPS structure of the pathogenic bacteria Mycobacterium tuberculosis was successfully solved using a loop truncation method, revealing differences and new insights into the stabilization mechanism of the enamine intermediate. The findings provide an opportunity for structure-based drug design to develop specific inhibitors for M. tuberculosis DXPS.

SCIENTIFIC REPORTS (2022)

Review Immunology

Novel Highlight in Malarial Drug Discovery: Aspartate Transcarbamoylase

Chao Wang, Arne Krueger, Xiaochen Du, Carsten Wrenger, Matthew R. Groves

Summary: Malaria, as one of the most serious and dangerous tropical diseases, requires the development of new antimalarials due to the high mutation rate and rapid adaptation of the parasite. The pyrimidine biosynthesis pathway is crucial for cell growth and proliferation, especially for the malarial parasite which lacks a functional pyrimidine salvage pathway. Aspartate transcarbamoylase (ATCase) has been identified as a promising target for both anti-malaria and anti-cancer drug development. The recent discovery of an allosteric pocket in the human homology raises the possibility of developing species-selective ATCase inhibitors.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)

Article Genetics & Heredity

Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance

Fatemeh Ghorbani, Mohamed Z. Alimohamed, Juliana F. Vilacha, Krista K. Van Dijk, Jelkje De Boer-Bergsma, Michiel R. Fokkens, Henny Lemmink, Rolf H. Sijmons, Birgit Sikkema-Raddatz, Matthew R. Groves, Corien C. Verschuuren-Bemelmans, Dineke S. Verbeek, Cleo C. Van Diemen, Helga Westers

Summary: Spinocerebellar ataxia (SCA) is a group of neurodegenerative disorders with autosomal dominant inheritance. Genetic testing plays an important role in the diagnosis, prognosis and risk assessment for patients and their families. This study addressed the challenge of prioritizing variants with unknown significance (VUSes) for follow-up, and successfully increased the molecular diagnostic yield by 1.1% through reclassification of VUSes.

FRONTIERS IN GENETICS (2022)

Article Chemistry, Medicinal

Multicomponent Macrocyclic IL-17a Modifier

Eman Abdelraheem, Max Lubberink, Wenja Wang, Jingyao Li, Atilio Reyes Romero, Robin van der Straat, Xiaochen Du, Matthew Groves, Alexander Doemling

Summary: IL-17a is a major inflammation target, with the emergence of small-molecule IL-17a antagonists as a hot topic. Research has found that all described IL-17a modifiers belong to the same pharmacophore model.

ACS MEDICINAL CHEMISTRY LETTERS (2022)

Article Biochemistry & Molecular Biology

Structural Characterization and Extended Substrate Scope Analysis of Two Mg2+-Dependent O-Methyltransferases from Bacteria

Nika Sokolova, Lili Zhang, Sadaf Deravi, Rick Oerlemans, Matthew R. Groves, Kristina Haslinger

Summary: Oxygen-directed methylation is a common tailoring reaction in natural product pathways catalyzed by O-methyltransferases (OMTs). Two bacterial OMTs from Desulforomonas acetoxidans and Streptomyces avermitilis were characterized for their enzymatic properties and substrate scope, and their crystal structures were determined. Both OMTs methylated a wide range of catechol-like substrates, including flavonoids, coumarins, hydroxybenzoic acids, and their respective aldehydes, an anthraquinone and an indole. This study expands knowledge on the substrate preference and structural diversity of bacterial catechol OMTs and opens up possibilities for their use in (combinatorial) pathway engineering.

CHEMBIOCHEM (2023)

Article Chemistry, Medicinal

Inhibitors of Aspartate Transcarbamoylase Inhibit Mycobacterium tuberculosis Growth

Xiaochen Du, Vidhisha Sonawane, Bidong Zhang, Chao Wang, Bram de Ruijter, Alexander S. S. Domling, Norbert Reiling, Matthew R. Groves

Summary: Aspartate transcarbamoylase (ATCase) is a target for suppressing cell proliferation in E. coli, human cells and the malarial parasite. This study aimed to test if a library of ATCase inhibitors developed for malarial ATCase (PfATCase) also inhibit the tubercular ATCase and show similar effects on cellular proliferation. Screening of 70 compounds revealed 10 inhibitors with single-digit micromolar inhibition in vitro, and the most promising compound showed a MIC90 of 4 μM against M. tuberculosis cell growth. In silico docking experiments explained the species selectivity observed for this compound series.

CHEMMEDCHEM (2023)

Article Biochemical Research Methods

Determination of Binding Sites on Trastuzumab and Pertuzumab to Selective Affimers Using Hydrogen-Deuterium Exchange Mass Spectrometry

Oladapo Olaleye, Christian Graf, Baubek Spanov, Natalia Govorukhina, Matthew R. Groves, Nico C. van de Merbel, Rainer Bischoff

Summary: Hydrogen-deuterium exchange mass spectrometry (HDX-MS) is a method to study the solvent accessibility and conformational dynamics of proteins. In this study, HDX-MS was used to determine the binding sites of Affimer reagents on monoclonal antibodies trastuzumab and pertuzumab. The results showed that the affimer binding led to significant protection in the Fab region of the antibodies. The binding sites of the affimer reagents were mainly located in the CDR2 of the heavy chain of the antibodies, as revealed by bottom-up HDX-MS experiments.

JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY (2023)

Article Crystallography

Structure of Mycobacterium tuberculosis 1-Deoxy-D-Xylulose 5-Phosphate Synthase in Complex with Butylacetylphosphonate

Victor Oliveira Gawriljuk, Rick Oerlemans, Robin M. Gierse, Riya Jotwani, Anna K. H. Hirsch, Matthew R. Groves

Summary: The development of new antibiotics is stagnant, highlighting the need for drugs with novel modes of action to combat antibiotic resistance. A study focuses on 1-deoxy-D-xylulose 5-phosphate synthase (DXPS), the rate-limiting enzyme in the methylerythritol phosphate pathway used by bacteria to synthesize important precursors. The crystal structure of M. tuberculosis DXPS in complex with the inhibitor butylacetylphosphonate (BAP) reveals its binding mode and provides insights for enhancing the activity of alkylacetylphosphonates (alkylAPs) against M. tuberculosis.

CRYSTALS (2023)

Review Oncology

A comprehensive overview of the heterogeneity of EGFR exon 20 variants in NSCLC and (pre)clinical activity to currently available treatments

Fenneke Zwierenga, Bianca A. M. H. van Veggel, Anke Van den Berg, Harry J. M. Groen, Lili Zhang, Matthew R. Groves, K. Kok, E. F. Smit, T. Jeroen N. Hiltermann, Adrianus J. de Langen, Anthonie J. Van der Wekken

Summary: This article provides a comprehensive assessment of drug sensitivity in vitro and in clinical settings for EGFRex20+ mutations in NSCLC. The activating A763_Y764insFQEA mutation shows better tumor response compared to mutations in other regions, suggesting the need for different treatment approaches. Classification beyond exon-based categories is necessary due to marked differences in treatment responses among EGFRex20+ mutations.

CANCER TREATMENT REVIEWS (2023)

Article Biochemistry & Molecular Biology

Identification and characterization of a small molecule that activates thiosulfate sulfurtransferase and stimulates mitochondrial respiration

Zeyana M. Al-Dahmani, Mojgan Hadian, Angel J. Ruiz-Moreno, Sabogal-Guaqueta Angelica Maria, Fernando A. Batista, Ran Zhang, Yang Luo, Afsaneh Sadremomtaz, Robin van der Straat, Mette Spoor, Amalia M. Dolga, Frank J. Dekker, S. S. Alexander Domling, Harry van Goor, Matthew R. Groves

Summary: A small molecule activator of human TST, identified through screening, increases TST activity and may have therapeutic benefits for diabetes and obesity. Two distinct isomers and an allosteric mode of activation are required for full activation. Molecular docking and dynamics suggest an allosteric site for the activator's binding, and increased TST activity enhances mitochondrial respiration.

PROTEIN SCIENCE (2023)

Article Biochemistry & Molecular Biology

Thiosulfate sulfurtransferase deficiency promotes oxidative distress and aberrant NRF2 function in the brain

Yang Luo, Laurent Chatre, Shaden Melhem, Zayana M. Al-Dahmani, Natalie Z. M. Homer, Anneke Miedema, Leo E. Deelman, Matthew R. Groves, Martin Feelisch, Nicholas M. Morton, Amalia Dolga, Harry van Goor

Summary: This study reveals that TST deficiency leads to disturbances in the reactive species interactome in the brain cortex, resulting in altered ROS and RSS (specifically, polysulfide) generation, as well as mitochondrial OXPHOS remodeling. These changes are associated with abnormal Nrf2-Keap1 expression and thiol-dependent antioxidant function. Tst-/- mice exhibit lower antioxidant capacity compared to wildtype controls when challenged with the redox-active herbicide paraquat.

REDOX BIOLOGY (2023)

No Data Available